Selectis Health, Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$10M
↓-7.0% -$725Kvs FY2024 (Q4)
Gross Profit
$10M
↓-7.0% -$725Kvs FY2024 (Q4)
Operating Income
$2M
↑+10.8% +$235Kvs FY2024 (Q4)
Net Income
$2M
↓-8.9% -$161Kvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $10M | $10M |
| COGS | $0 | $0 |
| Gross Profit | $10M | $10M |
| R&D | $0 | $0 |
| SG&A | $0 | $0 |
| D&A | $267K | $363K |
| Other OpEx | $7M | $8M |
| Operating Income | $2M | $2M |
| Interest Exp. | $752K | $356K |
| Other Non-Op | $0 | $0 |
| Pretax Income | $2M | $2M |
| Tax | $0 | $0 |
| Net Income | $2M | $2M |
QuarterCharts · SEC EDGAR data · GBCS · Comparing FY2025 (Q4) vs FY2024 (Q4)